Volume 20, Issue 2 (5-2017)                   J Arak Uni Med Sci 2017, 20(2): 46-53 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rastegarpouyani H, Hosseini S M, Mohebbi S R, Azimzadeh P, Kazemian S, Saeedi Niasar M, et al . Study of Parvovirus 4 Infection in HCV Infected Patients and Healthy Individuals Referred to Taleghani Hospital, Tehran. J Arak Uni Med Sci. 2017; 20 (2) :46-53
URL: http://amuj.arakmu.ac.ir/article-1-4470-en.html
Assistant Professor, PhD of Virology, Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran , srmohebbi@sbmu.ac.ir
Abstract:   (1896 Views)

Background: Parvovirus 4 (PARV4) was first discovered in 2005, in a hepatitis B virus–infected injecting drug user (IDU). To date, the best evidence about PARV4 transmission is parenteral roots and comes from IDU individuals. It seems that the prevalence of the virus in the normal population is very low. In this study, we investigated the prevalence of PARV4 virus among patients with chronic HCV infection compared with healthy controls and related risk factors among these groups.

Materials and Methods: A total of 206 patients, including 103 patients with chronic HCV infection and 103 healthy controls, were studied by use of nested-PCR and also real-time PCR techniques.

Results: AST enzyme levels with a mean of 40.45+34.84 and 18.58+5.9 in patients and healthy group respectively and the amount of enzyme ALT among patients with a mean of 40.45+35.75 and 21.50+11.35 in patients and healthy group respectively, were reported. Finally, after screening all DNA samples from patients and controls, we discovered that none of these people are infected with the PARV4 virus.

Conclusion: This study is the first to investigate the occurrence of PARV4 among HCV patients in Iran. The results show that, the virus is not important in Iranian population, even in patients with blood born infections such as HCV and further studies in other areas and various groups are required.

Full-Text [PDF 857 kb]   (380 Downloads)    
Type of Study: Original Atricle | Subject: Infection
Received: 2016/06/8 | Accepted: 2017/03/12 | Published: 2017/04/19

Add your comments about this article : Your username or Email:

Send email to the article author

© 2018 All Rights Reserved | Journal of Arak University of Medical Sciences

Designed & Developed by : Yektaweb